In brief
Consumer NZ tested ten widely sold sunscreens, finding that seven did not meet their claimed sun‑protection factor, with an SPF‑50 product only yielding SPF‑14. All products did meet broad‑spectrum standards, but the gaps in testing frequency expose regulatory lapses. The findings highlight the need for regular independent trials and clearer certification rules to protect consumers in a country with high skin‑cancer rates.
Seven out of ten sunscreens sold in New Zealand were found to under‑perform their advertised Sun Protection Factor (SPF) claims, a revelation from Consumer NZ’s latest independent lab test. In the most dramatic case, a product labelled SPF‑50 produced only SPF‑14 when measured by the group’s standard protocol.
Consumer NZ selected ten sunscreens that cover a broad price range—from $4 to $76 for 100 ml—to represent “widely available” products in the local market. All ten passed the industry‑required broad‑spectrum protection test, confirming they contain adequate UV‑B and UV‑A filters, but only three met or exceeded the SPF values advertised on their packaging.
"New Zealand has one of the highest skin cancer and melanoma rates in the world," said Belinda Castles, researcher with Consumer NZ. "Sunscreen plays an important role in preventing skin cancer, so the fact that most products under‑perform is deeply concerning."
Consumer NZ’s test protocol applies the same UV‑transmittance methodology used by international bodies, allowing the organisation to benchmark each product’s true protection level. The group noted that four of the seven failing sunscreens still offered “high protection”—above SPF‑25—yet the discrepancy between label and lab value poses an issue for consumers who may apply less product than needed to achieve the promised protection.
One of the sunscreens that failed was the most expensive tested, suggesting that higher price does not guarantee better performance. The fact that the SPF‑50 labelled product only delivered SPF‑14 highlights the potential market mislabeling problem. While the product still delivered broad‑spectrum coverage, consumers cannot rely on the label to determine how much they need to apply for effective protection.
Consumer NZ warned that there are currently no regulatory mandates in New Zealand specifying how often sunscreens must be independently tested before they reach shelves. In previous investigations, the group identified that some manufacturers had used test reports that were several years old—updating approvals only when new formulations were introduced.
"The lack of a mandatory testing cadence is a regulatory gap that allows sub‑par products to enter the market," said Castles. "A periodic, publicly‑recorded peer review process would close this loophole and give consumers confidence in the products they purchase."
Health experts believe that even partial mislabeling can contribute to under‑application. A common mistake among users is to apply only a fingertip’s worth of sunscreen for extensive sun exposure, assuming the product’s SPF will deliver the advertised protection. When the true SPF falls short, the risk of sunburn and long‑term skin damage increases.
New Zealand’s Ministry of Health has requested the Consumer NZ findings be examined, and a joint committee will review current lab testing frameworks. Potential reforms include mandatory re‑testing intervals—such as a renewal every two years—and publicly available test results alongside product labels.
In addition to regulatory changes, Consumer NZ recommends that consumers verify sunscreens against third‑party certification guidelines, such as those issued by the American Academy of Dermatology or the Australian/ New Zealand Institute of Dermatology (ANZID). These independent standards provide an extra layer of assurance when manufacturers rely on company‑issued test reports.
While the study focuses on performance, it also opens the conversation around the environmental impact of sunscreen ingredients. Consumers increasingly scrutinise formulations for reef‑safe and biodegradable alternatives—a trend aligning with global climate‑adversity considerations. The absence of clear labeling on both efficacy and environmental risk represents a missed communication opportunity for well‑intentioned brands.
Consumer NZ is not the only organisation to reveal potential mislabeling. In the United States, a series of tests by the consumer‑rights group Consumer Reports highlighted similar discrepancies in SPF claims, which has prompted state‑level investigations. Such cross‑border findings underscore the universal nature of this product‑testing challenge.
Communities of eco‑activists are calling for a harmonised, international framework that standardises product testing and reporting. A global approach would help ensure that environmentally responsible ingredients and effective protection go hand‑in‑hand across markets.
In closing, while the majority of sunscreens still grant adequate broad‑spectrum coverage, the significant gap between advertised and actual SPF raises both public‑health and regulatory alarms. Consumer NZ’s call for regular, independent testing is a step toward safeguarding consumers from misinformation and ensuring that sunscreen purchase decisions are based on real, reliable efficacy data.
